Section Chief, Oncology
Pediatric Hematology & Oncology
Dr. Alan S. Gamis, MD
|
|
Give Review
Alan Gamis is an expert in the field of Pediatric Hematology & Oncology. He went to University of Illinois College of Medicine. He received 3 awards: "Regional Top Doctor", "Super Doctor" and "Fellow (FAAP)". Alan Gamis is a published doctor as well. He has 72 publications published. The latest was: Use of DNA polymorphisms to monitor engraftment after allogeneic bone marrow transplantation.
Publications
- CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
- Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with Acute myeloid leukemia: A report from the Children's Onc...
- Immune-related conditions and Acute leukemia in children with Down syndrome: A Children's Oncology Group report.
- A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary Acute myeloid leuke...
- AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent Acute myeloid ...
- High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric Acute myeloid leukemia: a report from the Children's Oncology Group.
- Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncolog...
- Differences in outcomes of newly diagnosed Acute myeloid leukemia for adolescent/young adult and younger patients: A Report from the Children's Oncology Group.
- High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric Acute myeloid leukaemia: a report from the children's oncology...
- The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group.
- Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo Acute...
- Significance of expression of ITGA5 and its splice variants in Acute myeloid leukemia: A report from the Children's Oncology Group.
- Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Contai...
- Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory Acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group.
- High expression of neutrophil elastase predicts improved survival in pediatric Acute myeloid leukemia: a report from the Children's Oncology Group.
- Relationship between pediatric blood and marrow transplant center volume and day +100 mortality: Pediatric Blood and Marrow Transplant Consortium experience.
- Predictors and short-term outcomes of hyperleukocytosis in children with Acute myeloid leukemia: a report from the Children's Oncology Group.
- Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.
- Favorable survival maintained in children who have myeloid Leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2...
- Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo Acute myeloid leukemia: a report from Children's Onco...
- FLT3 mutation status is a predictor of early death in pediatric Acute promyelocytic leukemia: a report from the Children's Oncology Group.
- Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.
- Variation in Prescribing Patterns and Therapeutic Drug Monitoring of Intravenous Busulfan in Pediatric Hematopoietic Cell Transplant Recipients.
- Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical tr...
- Correlation of CD33 expression level with Disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood Acute myeloid leukemia: A report from the...
- Life-threatening and fatal infections in children with Acute myeloid leukemia: a report from the Children's Oncology Group.
- A phase II study of amifostine in children with myelodysplastic syndrome: A report from the Children's Oncology Group study (AAML0121).
- Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.
- Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
- Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
- WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric ac...
- Prognostic factors in pediatric Acute myeloid leukemia.
- Bowel obstruction after treatment of intra-abdominal tumors.
- Differentiating between congenital rhabdomyoSarcoma versus fibromatosis of the pediatric tongue.
- Allogeneic marrow transplantation in children with Acute leukemia: careful comparison with chemotherapy alternatives required.
- High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric Acute myeloid leukemia: a report f...
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
- Successful mobilization with AMD3100 and filgrastim with engraftment of autologous peripheral blood stem Cells in a heavily pretreated pediatric patient with recurren...
- Mutational analysis of candidate tumor-associated genes in Acute megakaryoblastic leukemia.
- International variations in infection supportive care practices for paediatric patients with Acute myeloid leukaemia.
- Hematopoietic colony-stimulating factor priming does not influence survival in Acute myeloid leukemia: a meta-analysis of randomized trials.
- Infections and association with different intensity of chemotherapy in children with Acute myeloid leukemia.
- Respiratory syncytial virus infections in children with Acute myeloid leukemia: a report from the Children''s Oncology Group.
- Congenital abnormalities and Acute leukemia among children with Down syndrome: a Children's Oncology Group study.
- Preservation of fertility in pediatric and adolescent patients with Cancer.
- Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
- Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
- Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid Leukemia of Down syndrome blasts in children with Down syndrome.
- Exposure to medical test irradiation and Acute leukemia among children with Down syndrome: a report from the Children's Oncology Group.
- Surveys: a tool to provoke thought and identify areas of need.
- Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
- Mutations in GATA1 in both transient myeloproliferative disorder and Acute megakaryoblastic leukemia of Down syndrome.
- Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and Acute myeloid leukemia: a report from the Children's Cance...
- Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory Acute myeloid leukemia: C...
- Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
- Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding he...
- Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with Acute myelogenous leukemia (A...
- Alpha hemolytic streptococcal infection during intensive treatment for Acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.
- Use of DNA polymorphisms to monitor engraftment after allogeneic bone marrow transplantation.
- Adenocarcinoma of minor salivary gland origin with skeletal metastasis in a child.
- Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis.
- Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous Leukemia in children.
- Disseminated infection with Fusarium in recipients of bone marrow transplants.
- Neuropsychologic (cognitive) disabilities in long-term survivors of childhood Cancer.
- Diffuse bony metastases at presentation in a child with glioblastoma multiforme. A case report.
- Bilirubinuria: an early indicator of gallbladder hydrops associated with Kawasaki Disease.
- Nitrous oxide analgesia in a pediatric emergency department.
- Acute acetone intoxication in a pediatric patient.
- High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric Acute myeloid leukemia: a report from the ...
Schools
University of Illinois At Chicago College of Medicine
Chldns Mercy HospU Mo Kc
University Minnesota
Conditions Treated
- Acute Leukemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- Super Doctor
- Fellow (FAAP)
Education
-
University of Minnesota at Fairview -
University of Illinois College of Medicine
Hospital
-
Children's Mercy Hospitals and Clinics
Helpful Reviews
Similar Doctors
|
|
Dr. Keith J. August, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maxine L. Hetherington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin M. Guest, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa S. Rayburg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard J. McKittrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Elliott, MD |
|
|
Dr. Karen B. Lewing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenson Samuel, MD
This Doctor is OpenDoctor Recommended.
|